Safety and Tolerability Study Comparing Sodium Oxybate Given as an Oral Solution to a Single-Blinded Combination of Oral Tablets Plus Oral Solution in Subjects With Fibromyalgia.
Phase of Trial: Phase III
Latest Information Update: 18 Aug 2011
At a glance
- Drugs Sodium oxybate (Primary)
- Indications Fibromyalgia
- Focus Adverse reactions
- 18 Aug 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 19 Apr 2011 Planned end date changed from 1 Dec 2010 to 1 Jul 2010 as reported by ClinicalTrials.gov.
- 28 May 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.